3X4 Genetics
PrivateLast Round
Series A
Dec 12, 2019
Total Funding Raised
$2.5M
Company Overview
3X4 Genetics operates in Healthcare & Life Sciences and is based in Bellevue, Washington. Its latest recorded funding round was a Series A round in December 2019.
3X4 Genetics is a health technology company that provides a genetics-based health assessment platform using a DNA test to offer personalized wellness insights.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
3X4 Genetics Comparables
Compare 3X4 Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The DNA Company | 87% | |
| Nutrigenomix | 84% | |
| IntellxxDNA | 84% |
For institutional investors. Book with your work email.
3X4 Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 12, 2019 | ||||
| Angel | Jan 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
3X4 Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alethea Capital Management, LLC | Series A |
| HAVAÍC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 42% MoM to 69.7K.
- Jun 6, 2025
Grew 15% QoQ, from 33 to 38 employees.
For institutional investors. Book with your work email.
3X4 Genetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 3X4 Genetics's valuation, stock price, and market status.
Is 3X4 Genetics a public or private company?
3X4 Genetics is a private company.
What is the current stock price of 3X4 Genetics?
3X4 Genetics is a private company, so its shares have no public market price. Caplight tracks 3X4 Genetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 3X4 Genetics worth (valuation)?
Valuation information for 3X4 Genetics is not publicly available.
Can I buy 3X4 Genetics stock?
3X4 Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 3X4 Genetics's last funding round?
3X4 Genetics's most recent funding round was Series A on December 12, 2019.
Who are the main investors in 3X4 Genetics?
Key investors in 3X4 Genetics include Alethea Capital Management, LLC.
Will 3X4 Genetics IPO soon?
No public IPO plans have been announced for 3X4 Genetics.
How can I track 3X4 Genetics secondary market activity?
Caplight tracks bids, offers, and trades in 3X4 Genetics's shares on secondary markets.